IvelinRadkov/iStock via Getty Images
Avidity Biosciences (NASDAQ:RNA) has announced new data from its clinical trials evaluating the experimental treatment del-zota for Duchenne muscular dystrophy.
After one year of continuous treatment, participants showed not only a halt in disease progression, but also measurable improvements compared to their
The Securities and Exchange Board of India (Sebi) on Friday proposed a revamp of the way stockbrokers calculate their variable...
Accounting used to be a career. It was long hours, but the promise of a six-figure salary, healthy benefits, and...
Businesses have doled out as much as $4 million for last-minute plans to move boats through the Panama Canal in recent weeks,...
A surge for Intel following a blowout profit report led the U.S. stock market to more records Friday, while oil...
The closed Strait of Hormuz has triggered a sharp energy shock across Asia. Last year, nearly 90% of the oil...
Energy experts have been warning oil futures have been totally disconnected from the reality that exists in the physical market,...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
